From: Novel stability-indicating RP-UPLC method for simultaneous estimation of sitagliptin and ertugliflozin in bulk and pharmaceutical formulations
Drug
Level of addition
Amount added
Drug found (mg/ml)
% Recovery
Average % recovery
(%)
(mg)
Mean±SD
Sitagliptin
50
50.1±0.26
100.2±0.51
100.2±0.57
100
99.7±0.5
150
151.1±0.26
100.7±0.17